Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Curran

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitorsDavid B Belanger, Patrick J Curran, Alan Hruza, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitorsHongbo Zeng, David B Belanger, Patrick J Curran, et al.
BMJ Global Health|March 24, 2021
Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, YemenEmilie S Koum Besson, Andy Norris, Abdulla S Bin Ghouth, et al.
International Journal of Behavioral Development|October 24, 2017
Examining Cohort Effects in Developmental Trajectories of Substance UseAlison R Burns, Andrea M Hussong, Jessica M Solis, et al.
Journal of Psychopathology and Clinical Science|April 10, 2025
Pathways to alcohol use and problems in adulthood for children with attention-deficit/hyperactivity disorder (ADHD): The role of common impairments above and beyond ADHD symptom persistenceBrooke S G Molina, Christine A P Walther, Frances L Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Aminothiazole inhibitors of HCV RNA polymeraseGerald W Shipps, Yongqi Deng, Tong Wang, et al.
The American Journal of Cardiology|September 22, 2007
Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary interventionEugene H Chung, Patrick J Curran, Satish Sivasankaran, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymeraseJaneta Popovici-Muller, Gerald W Shipps, Kristin E Rosner, et al.
SLAS Discovery : Advancing Life Sciences R & D|November 9, 2019
Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical SpaceNoreen F Rizvi, John P Santa Maria, Ali Nahvi, et al.
JCI Insight|September 22, 2022
Molecular and behavioral consequences of Ube3a gene overdosage in miceA Mattijs Punt, Matthew C Judson, Michael S Sidorov, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitorsDavid B Belanger, Patrick J Curran, Alan Hruza, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitorsHongbo Zeng, David B Belanger, Patrick J Curran, et al.
BMJ Global Health|March 24, 2021
Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, YemenEmilie S Koum Besson, Andy Norris, Abdulla S Bin Ghouth, et al.
International Journal of Behavioral Development|October 24, 2017
Examining Cohort Effects in Developmental Trajectories of Substance UseAlison R Burns, Andrea M Hussong, Jessica M Solis, et al.
Journal of Psychopathology and Clinical Science|April 10, 2025
Pathways to alcohol use and problems in adulthood for children with attention-deficit/hyperactivity disorder (ADHD): The role of common impairments above and beyond ADHD symptom persistenceBrooke S G Molina, Christine A P Walther, Frances L Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Aminothiazole inhibitors of HCV RNA polymeraseGerald W Shipps, Yongqi Deng, Tong Wang, et al.
The American Journal of Cardiology|September 22, 2007
Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary interventionEugene H Chung, Patrick J Curran, Satish Sivasankaran, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymeraseJaneta Popovici-Muller, Gerald W Shipps, Kristin E Rosner, et al.
SLAS Discovery : Advancing Life Sciences R & D|November 9, 2019
Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical SpaceNoreen F Rizvi, John P Santa Maria, Ali Nahvi, et al.
JCI Insight|September 22, 2022
Molecular and behavioral consequences of Ube3a gene overdosage in miceA Mattijs Punt, Matthew C Judson, Michael S Sidorov, et al.
Pageof 7